Geode Capital Management, LLC Citius Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,878,953 shares of CTXR stock, worth $244,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,878,953

Previous 1,646,297 14.13%

Holding current value

$244,263

Previous $954,000 1.57%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.48 - $1.02 $111,674 - $237,309	232,656 Added 14.13%	1,878,953 $939,000
Q2 2024 Aug 09, 2024	SELL	$0.58 - $1.03 $753,534 - $1.34 Million	-1,299,197 Reduced 44.11%	1,646,297 $954,000
Q1 2024 May 13, 2024	BUY	$0.6 - $0.9 $99,351 - $149,027	165,586 Added 5.96%	2,945,494 $2.65 Million
Q4 2023 Feb 13, 2024	BUY	$0.65 - $0.86 $67,946 - $89,898	104,533 Added 3.91%	2,779,908 $2.11 Million
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.25 $43,772 - $84,177	67,342 Added 2.58%	2,675,375 $1.82 Million
Q2 2023 Aug 11, 2023	BUY	$1.08 - $1.65 $1.37 Million - $2.09 Million	1,269,256 Added 94.81%	2,608,033 $3.13 Million
Q1 2023 May 15, 2023	BUY	$0.78 - $1.42 $4,800 - $8,738	6,154 Added 0.46%	1,338,777 $1.57 Million
Q4 2022 Feb 13, 2023	BUY	$0.79 - $1.28 $7,368 - $11,938	9,327 Added 0.7%	1,332,623 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $1,853 - $17,605	13,237 Added 1.01%	1,323,296 $1.6 Million
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $846,635 - $1.8 Million	-962,086 Reduced 42.34%	1,310,059 $1.21 Million
Q1 2022 May 13, 2022	BUY	$1.38 - $1.89 $307,639 - $421,332	222,927 Added 10.88%	2,272,145 $4.07 Million
Q4 2021 Feb 11, 2022	SELL	$1.51 - $2.2 $123,675 - $180,188	-81,904 Reduced 3.84%	2,049,218 $3.16 Million
Q3 2021 Nov 12, 2021	BUY	$1.74 - $2.6 $392,568 - $586,596	225,614 Added 11.84%	2,131,122 $4.33 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $1.59 Million - $4.45 Million	1,051,301 Added 123.07%	1,905,508 $6.63 Million
Q1 2021 May 12, 2021	BUY	$1.04 - $2.34 $737,628 - $1.66 Million	709,258 Added 489.32%	854,207 $1.52 Million
Q3 2020 Nov 13, 2020	BUY	$0.83 - $1.51 $62,832 - $114,310	75,702 Added 109.32%	144,949 $150,000
Q2 2020 Aug 13, 2020	BUY	$0.65 - $1.45 $45,010 - $100,408	69,247 New	69,247 $78,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

23.7M

Call Options Held

83.1K

Put Options Held

32.1K

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $19M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Citius Pharmaceuticals, Inc. Transaction History